These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2796286)

  • 1. IgA nephropathy: overproduction or decreased clearance of immune complexes?
    Emancipator SN; Lamm ME
    Lab Invest; 1989 Oct; 61(4):365-7. PubMed ID: 2796286
    [No Abstract]   [Full Text] [Related]  

  • 2. IgA-CD89 complex in IgA nephropathy: a study on molecular function.
    Wiwanitkit V
    Ren Fail; 2006; 28(6):457-9. PubMed ID: 16928613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and biological activities of immune complexes are determined by their size and composition.
    Matousovic K; Novak J; Julian BA; Mestecky J
    Nephrol Dial Transplant; 2010 Mar; 25(3):1007. PubMed ID: 19914998
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental IgA nephropathy. Factors governing the persistence of IgA-antigen complexes in the circulation of mice.
    Rifai A; Small P; Ayoub EM
    Contrib Nephrol; 1984; 40():37-44. PubMed ID: 6499461
    [No Abstract]   [Full Text] [Related]  

  • 5. IgA nephropathy: clearance kinetics of IgA-containing immune complexes.
    Chen A; Yang SS; Lin TJ; Ka SM
    Semin Immunopathol; 2018 Nov; 40(6):539-543. PubMed ID: 30218212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is sialylation of IgA the agent provocateur of IgA nephropathy?
    Smith A; Molyneux K; Feehally J; Barratt J
    Nephrol Dial Transplant; 2008 Jul; 23(7):2176-8. PubMed ID: 18477571
    [No Abstract]   [Full Text] [Related]  

  • 7. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
    Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
    Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective hepatic handling of IgA immune aggregates by mice with experimental IgA nephropathy.
    González E; González-Cabrero J; Egido J
    Immunology; 1989 Jul; 67(3):308-13. PubMed ID: 2759657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance kinetics and fate of macromolecular IgA in patients with IgA nephropathy.
    Rifai A; Schena FP; Montinaro V; Mele M; D'Addabbo A; Nitti L; Pezzullo JC
    Lab Invest; 1989 Oct; 61(4):381-8. PubMed ID: 2796287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mucosal immune system and IgA nephropathy.
    Lamm ME; Emancipator SN
    Semin Nephrol; 1987 Dec; 7(4):280-2. PubMed ID: 3445008
    [No Abstract]   [Full Text] [Related]  

  • 11. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pathogenesis of primary IgA-nephropathy].
    van den Wall Bake AW; Daha MR; van Es LA
    Tijdschr Kindergeneeskd; 1990 Apr; 58(2):55-9. PubMed ID: 2190351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
    Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
    Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy.
    Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R
    Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576
    [No Abstract]   [Full Text] [Related]  

  • 16. IgA-nephropathy: triumph of immunology or misconception?
    Beukhof JR; Fleuren GJ; Hoedemaeker PJ; Donker AJ; The TH; Ockhuizen T; Van der Hem GK
    Neth J Med; 1984; 27(10):393-404. PubMed ID: 6392909
    [No Abstract]   [Full Text] [Related]  

  • 17. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and fate of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy.
    Roccatello D; Picciotto G; Ropolo R; Coppo R; Quattrocchio G; Cacace G; Molino A; Amoroso A; Baccega M; Isidoro C
    Lab Invest; 1992 Jan; 66(1):86-95. PubMed ID: 1731150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in IgA nephropathy.
    O'Donoghue DJ; Feehally J
    Contrib Nephrol; 1995; 111():93-103; discussion 104-6. PubMed ID: 7758352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.